Coronary Artery Disease Journal

OCTOBER 31, 2023

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. reduction in admissions in 2020. reduction in admissions in 2020. In 2020, 3.0% 12.55, P < 0.001) with COVID-19 infection compared with no infection.

COVID-19 52

COVID-19 STEMI Inpatient Hospital 52

Dr. Anish Koka

FEBRUARY 6, 2023

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID.

COVID-19 52

COVID-19 Chest Pain Academic Hospital 52

Open Heart

MARCH 28, 2023

Background COVID-19 pandemic led to a reduction in hospital admissions and intervention for other diseases in many countries. We aimed to assess the effect of COVID-19 pandemic on cardiovascular disease (CVD) hospitalisations, management and mortality in Switzerland.

COVID-19 52

COVID-19 Cardiovascular Disease Angioplasty Hospital 52

Frontiers in Cardiovascular Medicine

AUGUST 11, 2024

BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. This study aimed to identify the applications of telemedicine for cardiovascular diseases management during the Covid-19 pandemic.MethodsThis scoping study was conducted in 2023.

COVID-19 52

COVID-19 Technology Cardiovascular Disease Article 52

Open Heart

APRIL 20, 2022

Objective To assess the feasibility, efficacy and safety of performing exercise stress echocardiography (ESE) for the assessment of myocardial ischaemia during the COVID-19 pandemic. Of the 17 healthcare professionals performing ESE, none contracted COVID-19 during this period. SE service performance increased to 96.8%

COVID-19 52

COVID-19 Exercise Coronary Artery Disease Echocardiogram 52

Open Heart

JANUARY 27, 2022

Objectives (1) To evaluate the prevalence and hospitalisation rate of COVID-19 infections among patients with dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) in the Royal Brompton and Harefield Hospital Cardiovascular Research Centre (RBHH CRC) Biobank. (2) of the cardiomyopathy cohort reporting COVID-19 symptoms.

COVID-19 52

COVID-19 Cardiomyopathy Hospital Heart Disease 52

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Methods Data from the 2020 California State Inpatient Database was used retrospectively.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

Heart BMJ

NOVEMBER 27, 2023

We examined incidental non-COVID-19 cardiovascular pathology in college athletes undergoing postinfection return-to-play screening. Conclusion Major non-COVID-19 cardiovascular pathology was identified in 1/500 college athletes undergoing return-to-play screening.

COVID-19 52

COVID-19 Sudden Cardiac Death Aortic Atrial Fibrillation 52

Wellnest

JUNE 1, 2023

The World Health Organisation (WHO) formally proclaimed COVID-19, the illness spread by a zoonotic SARS-CoV-2, as a pandemic in March 2020, after it had started to spread in late 2019. And, addressing myocardial infarction, recent studies have shown that 1-4% of Athletes untimely die due to myocarditis caused by COVID-19.

COVID-19 52

COVID-19 Myocardial Infarction Thrombosis Academic 52

Open Heart

MAY 9, 2022

Objective To identify the most common transthoracic echocardiogram (TTE) parameters in patients hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) and their association with myocardial injury and outcomes. Moreover, COVID-19-induced myocarditis remains extremely rare.

COVID-19 52

COVID-19 Inpatient Risk Factors Echocardiogram 52

Frontiers in Cardiovascular Medicine

APRIL 16, 2024

The current pandemic of a new coronavirus infection, which began in March 2020, was marked by an increase in cardiovascular diseases, including an increase in the number of patients with AF. However, most research in this area has focused on hospital patients.

COVID-19 52

COVID-19 Atrial Fibrillation Quality of Life Outpatient 52

Open Heart

NOVEMBER 20, 2023

Background We sought to examine a 1-year incidence of atrial fibrillation (AF) among patients with SARS-CoV-2 virus (COVID-19) in comparison to those with non-COVID-19 acute upper respiratory infection (AURI). Similar findings were observed for the COVID-19 (n=169 687) versus AURI prepandemic (n=169 486) comparison (2.7%

COVID-19 52

COVID-19 Atrial Fibrillation 52

Science Daily - Heart Disease

APRIL 3, 2024

When the COVID-19 pandemic arrived in 2020, however, it derailed progress in many locations. Over the past three decades, reductions in death from leading killers fueled this progress, including diarrhea and lower respiratory infections, as well as stroke and ischemic heart disease.

COVID-19 89

COVID-19 Stroke Strokes Heart Disease 89

Dr. Prateek Bhatnagar

SEPTEMBER 14, 2020

Prateek Bhatnagar, Director Cardiac Surgery & Chief Cardiology Surgeon at Care Hospital, Banjara Hills, Hyderabad, has successfully operated & discharged India’s first post Covid 19 recovered patient who on 16th July, 2020, underwent a triple bypass surgery under Dr. Bhatnagar & his team of doctors here.

COVID-19 52

COVID-19 Chest Pain Pulmonary Coronary Artery Disease 52

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods

COVID-19 40

COVID-19 Hemorrhage Outcomes Nursing 40

Stroke Journal

FEBRUARY 1, 2024

Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed.

COVID-19 40

COVID-19 Hemorrhage Outcomes Inpatient 40

Open Heart

NOVEMBER 20, 2023

Aims We evaluated the effects of the COVID-19 pandemic on hospital admission and quality of care for acute coronary syndrome. Data were fitted to segmented regression models with March 2020 as the breakpoint. In patients with STEMI, the pandemic did not affect reperfusion rates (0.29%, (95% CI) –1.5%

COVID-19 52

COVID-19 Hospital Angina Myocardial Infarction 52

Heart BMJ

DECEMBER 23, 2024

Background Inconsistent findings about the impact of the COVID-19 pandemic on cardiovascular disease diagnosis and consultations have been reported internationally.

COVID-19 52

COVID-19 Heart Disease Chronic Disease Cardiovascular Disease 52

Open Heart

AUGUST 30, 2024

Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. OpenSAFELY can be used to continuously monitor changes in national quality-of-care schemes to identify changes in key clinical subgroups early and support prioritisation of recovery from care disrupted by COVID-19.

COVID-19 52

COVID-19 Blood Pressure Hypertension Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

Adult patients in 2018 (n=6,051,974) were compared to those in 2020 (n=5,470,813), the first year of the COVID-19 pandemic. To prevent potential confounding by undiagnosed COVID-19, patients in 2019 were not utilized in the analysis. Hospital mortality rate among CVT patients admitted in 2020 was 5%.

COVID-19 40

COVID-19 Thrombosis Inpatient Hospital 40

Circulation

NOVEMBER 11, 2024

Background:The COVID-19 pandemic has significantly exacerbated sleep problems. Changes in daily life due to COVID-19 were assessed by asking participants to score their current situation compared to their pre-pandemic situation, ranging from 100 (no change) to 0 (complete cessation of daily activities).

COVID-19 40

COVID-19 Public Health Risk Factors Circulation 40

Open Heart

JULY 17, 2023

Background COVID-19 has caused significant worldwide morbidity and mortality. Objective Ascertain the impact of COVID-19 on people with CHD and define risk factors for adverse outcomes. Methods Multicentre UK study undertaken 1 March 2020–30 June 2021 during the COVID-19 pandemic.

COVID-19 40

COVID-19 Congenital Heart Disease Congenital Heart Disease 40

Stroke Journal

FEBRUARY 1, 2024

Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%. but there were fewer women in the COVID-CVST group (50% vs 68%,P&lt;0.01).

COVID-19 40

COVID-19 Thrombosis Outcomes Hospital 40

HeartRhythm

MARCH 10, 2024

The outbreak of COVID-19 pandemic was first reported in China between December 2019 and January 2020 and then spread to Europe, with Italy among the first countries with recognized clusters. The COVID-19 pandemic turned everyone’s life upside down and the end of the emergency was declared by WHO only on May 5, 2023.

COVID-19 40

COVID-19 Electrophysiology Public Health 40

HCPLive

JANUARY 5, 2024

Telehealth visits increased during the COVID-19 pandemic, with a peak in April 2020. About half of primary care visits were telehealth, but the percentage declined and stabilized to about 8% in late 2021.

COVID-19 69

COVID-19 69

Circulation

NOVEMBER 11, 2024

Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiac arrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel. to 1.07; p = 0.24).

COVID-19 40

COVID-19 Cardiac Arrest Outcomes Hospital 40

Open Heart

JULY 17, 2023

Methods This observational case-control study included consecutive patients whose non-emergency cardiac intervention has been postponed during COVID-19-related lockdown between 19 March and 30 April 2020 (n=193). The planned intervention was deferred by a median of 23 (19–36) days.

COVID-19 52

COVID-19 Outcomes Cardiovascular Interventions Risk Factors 52

Stroke Journal

FEBRUARY 1, 2024

Background:Nationwide data demonstrating the impact of the COVID-19 pandemic on hemorrhagic stroke outcomes are lacking.Methods:We used the National Inpatient Sample (2016-2020) to identify adults (&gt;=18 years) with primary intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH). 2.51; SAH: 2.76, 1.68-4.54),

COVID-19 40

COVID-19 Hemorrhage Public Health Inpatient 40

Society of Thoracic Surgeons - Research

APRIL 12, 2021

The onset of the pandemic and the related public health emergency in early 2020 presented an opportunity for the Network to expand its focus beyond cardiac surgery and help design and execute COVID-19 studies. The performance of the Network has been spectacular,” said Peter K.

COVID-19 40

COVID-19 Research Cardiothoracic Public Health 40

Medical Xpress - Cardiology

JANUARY 24, 2024

New research confirms what public health leaders have been fearing: The significant uptick in the cardiovascular disease (CVD) death rate that began in 2020 has continued. The findings are reported in the American Journal of Preventive Medicine.

COVID-19 74

COVID-19 Public Health Cardiovascular Disease Heart Disease 74

Stroke Journal

DECEMBER 21, 2023

BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. We compared COVID-negative controls, AS-COVID, and S-COVID using multivariable regression. 2.32], respectively).

COVID-19 40

COVID-19 Outcomes Strokes Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Although Australia has been known to offer excellent stroke treatment and care services in recent years (Deloitte Access Economics, 2020), the rise of the COVID‐19 pandemic caused a reduction in resource availability and delays in stroke treatment.

COVID-19 40

COVID-19 Stroke Strokes Hospital 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe goal of this research project is to investigate the impacts and effects of the COVID‐19 pandemic on acute ischemic stroke treatment in North America. Among patients with an ischemic stroke, thrombectomy administration decreased by up to 25% in February 2020 compared to February 2019 (Zhao et al.,

COVID-19 40

COVID-19 Stroke Strokes Thrombolysis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe coronavirus disease 2019 (COVID‐19) pandemic has had a global impact on healthcare systems. There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. Of these, 45,979 occurred pre‐COVID and 11,736 during the COVID pandemic period.

COVID-19 40

COVID-19 Aneurysm Outcomes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

The COVID-19 pandemic developed midway through VIPS II enrollment, creating an opportunity to assess its impact.Methods:At 22 North American sites, we enrolled 205 children (28 days-18 years) with AIS (12/2016 - 1/2022), collected serum samples up to 7 days post-stroke, and measured clinical infection via parental interview.

COVID-19 40

COVID-19 Stroke Strokes Pediatrics 40

Circulation

NOVEMBER 11, 2024

Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. A retrospective chart review was performed on 41 patients with COVID-19 on ECMO between March and October 2020.

COVID-19 40

COVID-19 Laboratory Biomarkers Echocardiogram 40

Circulation

NOVEMBER 11, 2024

Background:It is still not well understood whether cardiac injury observed during acute COVID-19 infection extends after recovery from the initial viral infection. from March 2020 to October 2021. Adult patients were identified by hospitalizations using ICD-10 code U07.1

COVID-19 40

COVID-19 Echocardiogram Hospital Circulation 40